Cancer’s Complications: Confusing Bills, Maddening Errors And Endless Phone Calls
Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.
Cost and Quality
701-720 of 3,363 results
-
-
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
By Emmarie Huetteman and Jay Hancock -
Progressives Tout ‘Medicare-For-All’ But States Eye ‘Medicaid Buy-In’
New Mexico is one of several states looking at offering consumers a government-sponsored plan. The proposals would typically have benefits similar to what is available in Medicaid, the state-federal health plan for low-income people.
-
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
By Emmarie Huetteman and Jay Hancock -
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.
By Shefali Luthra and Phil Galewitz -
HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services from those providing abortions.
By Julie Rovner -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
By Jay Hancock -
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Glimpsing The Future At Gargantuan Health Tech Showcase
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
-
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
-
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
-
Vaccine Storage Too Often Fails To Meet Standards
Federal officials regulate the handling of vaccines that are provided through the Vaccines for Children program, which offers the medicines generally for children whose families could not afford them. But there is no federal oversight of how these drugs are stored among other health care providers.
-
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
By Sydney Lupkin and Jay Hancock -
Trump Pledges To End HIV Transmission By 2030. Doable, But Daunting.
The president’s promise to eliminate HIV transmission within 10 years is a goal long sought by advocates, but it won’t be an easy undertaking.
-
For California Attorney General Xavier Becerra, Resistance Is Personal
Xavier Becerra, the state’s first Latino attorney general, is one of President Donald Trump’s most relentless adversaries. He attributes his legal values — and his opposition to the current administration — to his upbringing as the son of Mexican immigrants.
-
Transparent Hospital Pricing Exposes Wild Fluctuation, Even Within Miles
A new federal rule requires hospitals to post their prices online. These lists reveal the wildly different charges for basic procedures and services, but consumers will have a hard time putting this information to use.
-
Task Force Outlines Strategy To Address California’s Shortfall Of Health Workers
A new report by a coalition of health, education and labor leaders concludes that the state must build a larger and more culturally diverse pool of medical, mental health and home care professionals to meet the needs of a growing population. The findings point to a big challenge for Gov. Gavin Newsom as he seeks to extend health insurance to many of California’s nearly 3 million uninsured residents.
By Anna Gorman